Nelson Sun Acquires 10,000 Shares of Aardvark Therapeutics, Inc. (NASDAQ:AARD) Stock

Aardvark Therapeutics, Inc. (NASDAQ:AARD) CFO Nelson Sun acquired 10,000 shares of the business’s stock in a transaction on Friday, February 14th. The shares were purchased at an average price of $16.00 per share, with a total value of $160,000.00. Following the transaction, the chief financial officer now owns 99,484 shares in the company, valued at $1,591,744. The trade was a 11.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Aardvark Therapeutics Price Performance

Shares of Aardvark Therapeutics stock opened at $17.25 on Friday. Aardvark Therapeutics, Inc. has a 52-week low of $11.55 and a 52-week high of $19.58.

About Aardvark Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients.